A multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and safety of SYR110322 (SYR-322) Compared with Placebo in Subjects with Type 2 Diabetes

Registry ID

EUCTR2005-004670-24

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Takeda Global Research & Development Center, Inc.

Start date

2006-03-15

Completion date

2007-07-05

Last update

2026-08-16

Conditions

• Type II diabetes mellitus.

Summary

• To evaluate the efficacy of SYR-322 as compared with placebo on glycosylated hemoglobin (HbA1c) change from baseline

Locations

• , , Czechia
• , , UK

View on source registry